Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJul 19, 2023Non-Drowsy Allergy ReliefFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0901-2023Class IITerminatedJul 19, 2023Allergy, Fexofenadine Hydrochloride TabletsFailed Impurities/Degradation SpecificationsL. Perrigo Company · D-0900-2023Class IIITerminatedJul 19, 2023Amlodipine Besylate TabletsSubpotent Drug: Out-of-Specification test results observed in assay test at 21-month long term stability study.Lupin Pharmaceuticals Inc. · D-0899-2023Class IIOngoingJul 19, 2023Dry Eye Relief Lubricant Eye DropsCGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.K.C. Pharmaceuticals, Inc · D-0898-2023Class IIOngoingJul 19, 2023Original Eye DropsCGMP Deviations: good manufacturing deficiencies related to a lack of documentation of the fill line.K.C. Pharmaceuticals, Inc · D-0897-2023Class IIIOngoingJul 19, 2023PANCREAZEFailed Stability SpecificationsVivus, Inc. · D-0896-2023Class IITerminatedJul 12, 2023Losartan Potassium TabletsPresence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.Strides Pharma Inc. · D-0895-2023Class IIOngoingJul 12, 2023Tizanidine Hydrochloride Tablet 4mgFailed Stability SpecificationsPreferred Pharmaceuticals, Inc. · D-0894-2023Class IITerminatedJul 12, 2023Tizanidine TabletsFailed Dissolution Specifications: this repackaged product was recalled by the manufacturer, Dr. Reddy's Laboratories, Inc., due to out of specification results for...Amerisource Health Services LLC · D-0892-2023Class IITerminatedJul 5, 2023Amphotericin B Liposome for InjectionSubpotent drugSun Pharmaceutical Industries Inc · D-0891-2023Class IITerminatedJul 5, 2023StellaLife VEGA Oral Care GelcGMP deviationsHomeocare Laboratories, Inc. · D-0890-2023Class IITerminatedJul 5, 2023StellaLife VEGA Oral Care GelcGMP deviationsHomeocare Laboratories, Inc. · D-0889-2023Class IITerminatedJul 5, 2023StellaLife VEGA Oral Care SpraycGMP deviationsHomeocare Laboratories, Inc. · D-0888-2023Class IITerminatedJul 5, 2023StellaLife VEGA Oral Care RinsecGMP deviationsHomeocare Laboratories, Inc. · D-0887-2023Class IITerminatedJul 5, 2023StellaLife VEGA Oral Care RinsecGMP deviationsHomeocare Laboratories, Inc. · D-0886-2023Class IITerminatedJul 5, 2023SnoreStop Naso Spray BulkcGMP deviationsHomeocare Laboratories, Inc. · D-0885-2023Class IITerminatedJul 5, 2023DoloEar Earache DropscGMP deviationsHomeocare Laboratories, Inc. · D-0884-2023Class IITerminatedJul 5, 2023Babelyn Diarrhea Drops Homeopathic RemedycGMP deviationsHomeocare Laboratories, Inc. · D-0883-2023Class IITerminatedJul 5, 2023Bebelyn Colic Drops Homeopathic RemedycGMP deviationsHomeocare Laboratories, Inc. · D-0882-2023Class IITerminatedJul 5, 2023Arnica 7 CreamcGMP deviationsHomeocare Laboratories, Inc. · D-0881-2023Class IITerminatedJul 5, 2023Kanjo Homeopathic Pain Relief Cream With ArnicacGMP deviationsHomeocare Laboratories, Inc. · D-0880-2023Class IITerminatedJul 5, 2023EndometrincGMP deviations: potential for Microbial Contamination of Non-Sterile ProductsFerring Pharmaceuticals Inc · D-0879-2023Class IITerminatedJul 5, 2023Tramadol Hydrochloride TabletsPackaging defect: blister packaging inadequately sealed.The Harvard Drug Group · D-0878-2023Class ITerminatedJun 28, 2023ZIPRASIDONE HYDROCHLORIDE CAPSULES 20 mgLabeling: Label Mix-up: Unit Dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg were found to contain blister packages labeled as and containing...The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · D-0893-2023Class IIITerminatedJun 28, 2023Glycopyrrolate TabletsFailed Impurities/Degradation SpecificationsAurolife Pharma, LLC · D-0877-2023Class IITerminatedJun 21, 2023Extended Phenytoin Sodium CapsulesFailed Dissolution Specifications: Out-of-specification results for dissolution (above specification)Amneal Pharmaceuticals of New York, LLC · D-0876-2023Class IIIOngoingJun 21, 2023Tranexamic Acid USP TabletsFailed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.Avkare LLC · D-0875-2023Class ITerminatedJun 21, 2023SOFT HANDS Alcohol Antiseptic 80%Chemical Contamination: FDA testing found Presence of methanolJarman's Midwest Cleaning Systems, Inc. · D-0874-2023Class ITerminatedJun 21, 2023Alcohol Antiseptic 80%Chemical Contamination: FDA testing found Presence of methanolJarman's Midwest Cleaning Systems, Inc. · D-0873-2023Class IITerminatedJun 21, 2023Isopropyl Alcohol Antiseptic 75%CGMP deficiencies: Product manufactured at the same site where FDA testing found Presence of methanol in other products.Jarman's Midwest Cleaning Systems, Inc. · D-0872-2023Class IIITerminatedJun 21, 2023LystedaFailed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.Amring Pharmaceuticals Inc · D-0871-2023Class IIITerminatedJun 14, 2023GLYCOPYRROLATE INJECTIONLabeling: Label Mix-upHF Acquisition Co LLC · D-0870-2023Class IITerminatedJun 14, 2023Buprenorphine Sublingual TabletsCGMP DeviationsSun Pharmaceutical Industries Inc · D-0869-2023Class IITerminatedJun 14, 2023Travoprost Ophthalmic SolutionLack of Assurance of Sterility: Tamper Evidence Seal is missing on secondary container.Golden State Medical Supply Inc. · D-0867-2023Class IITerminatedJun 14, 2023Levsin injectionCGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that...Viatris Inc · D-0866-2023Class IICompletedJun 14, 2023ASCORBIC ACID PRESERVED INJECTION SOLUTIONMislabeling: preservative free product labeled as preserved.Empower Clinic Services LLC dba Empower Pharmacy · D-0865-2023Class ITerminatedJun 7, 2023G-Supress DXProduct mix-up: incorrect product was found inside the G-Supress DX product carton.Novis PR, LLC dba Kramer Novis · D-0868-2023Class IIOngoingJun 7, 2023Tropicamide Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0864-2023Class IIOngoingJun 7, 2023Ropivacaine Hydrochloride Injection USPCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0863-2023Class IIOngoingJun 7, 2023Pilocarpine Hydrochloride Ophthalmic SolutionCGMP Deviations: Firm went out of business and could no longer continue stability studies.Akorn, Inc. · D-0862-2023